GVHD
BMT survivors 4 and has no effective therapy. New and novel modes of effective treatment are desperately needed Forsyth et al 1 reported a case of bronchiolitis obliterans but in view of the high incidence (up to 50%) of thalido-(BO) following allogeneic bone marrow transplant (BMT) mide-induced peripheral neuropathy, 5 as the authors have which resolved after a 10 month course of thalidomide.
pointed out, caution should be exercised in prescribing it. There are a number of points that need to be addressed before we can fully accept the diagnosis of BO complicat-F Chen 
